Diclofenac Sodium
- Product NDC
- 76420-861
- 11-digit product format
- 764200861
- Labeler code
- 76420
- Product ID
- 76420-861_239fc4df-8f2c-e524-e063-6394a90a2bae
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Diclofenac Sodium
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Labeler
- Asclemed USA, Inc
- Application
- ANDA213040
- Marketing category
- ANDA
- Marketing start
- 2023-02-03
- Substance
- DICLOFENAC SODIUM
- Active strength
- 20 mg/g
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Diclofenac Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DICLOFENAC SODIUM | 20 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | QTG126297Q |
| Rxcui | 1487074 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 76420-861-04 | Diclofenac Sodium | 112 g in 1 BOTTLE | SOLUTION | 112 | | 1 |
| 76420-861-04 | Diclofenac Sodium | 1 in 1 CARTON | SOLUTION | 1 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 76420-861 | DICLOFENAC SODIUM SOLUTION [ASCLEMED USA, INC] | 1 | Current NDC, 2 package rows | 20241127_2e3e6de9-7e07-4df3-9fea-ac50ddcde840.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 76420-861-04 | 76420086104 | 1 BOTTLE in 1 CARTON (76420-861-04) / 112 g in 1 BOTTLE | 1 bottle | 2024-10-04 | No | No | Historical |